VAT-free starting 2019: Medicines for diabetes, high cholesterol, hypertension
MANILA, Philippines – Filipinos who suffer from diabetes, high cholesterol, and hypertension could buy more medicine or save money when a provision in the tax reform law takes effect in 2019.
In a Facebook post on Thursday, December 27, the Department of Finance (DOF) reminded the public that starting January 1, 2019, the purchase of drugs or medicines prescribed for those ailments will no longer have any value-added tax (VAT) imposed on them.
This provision is stated in Section 109(AA) of the National Internal Revenue Code (NIRC), as amended by Section 34 of Republic Act 10963 or the Tax Reform for Acceleration and Inclusion (Train) Law, the first of a series of tax reform packages planned by President Rodrigo Duterte's administration.
Duterte signed the Train Law on December 19, 2017.
Section 109 of the NIRC lists down the transactions exempted from VAT.
DOF added that the guidelines for the implementation of this provision are outlined in Joint Administrative Order No. 2-2018 by the DOF, the Department of Health, the Bureau of Internal Revenue (BIR) and the Food and Drug Administration, as well as in BIR Revenue Regulations No. 25-2018. Both issuances were dated December 21, the DOF said. – Michael Bueza/Rappler.com
In these changing times, courage and clarity become even more important.
Take discussions to the next level with Rappler PLUS — your platform for deeper insights, closer collaboration, and meaningful action.
Sign up today and access exclusive content, events, and workshops curated especially for those who crave clarity and collaboration in an intelligent, action-oriented community.
As an added bonus, we’re also giving a free 1-year Booky Prime membership for the next 200 subscribers.
You can also support Rappler without a PLUS membership. Help us stay free and independent by making a donation: https://www.rappler.com/crowdfunding. Every contribution counts.